ASTH
Astrana Health, Inc.NASDAQHealthcare$25.05+2.20%ClosedMarket Cap: $1.26B
As of 2026-04-06
Valuation
P/E (TTM)
55.87
PEG
—
P/B
1.58
P/S
0.39
EV/EBITDA
14.81
DCF Value
$71.62
FCF Yield
8.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
9.7%
Operating Margin
2.5%
Net Margin
0.7%
ROE
2.9%
ROA
2.1%
ROIC
2.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $950.5M | 8.3% | $18.4M | $6.0M | $0.12 | — |
| FY 2025 | $3.18B | 9.3% | $78.5M | $22.5M | $0.46 | — |
| Q3 2025 | $956.0M | 8.5% | $19.2M | $373.0K | $0.01 | — |
| Q2 2025 | $654.8M | 11.9% | $20.3M | $9.4M | $0.19 | — |
| Q1 2025 | $620.4M | 11.5% | $20.6M | $6.7M | $0.14 | — |
| Q4 2024 | $665.2M | 9.5% | $720.0K | $-7.0M | $-0.14 | — |
| FY 2024 | $2.03B | 13.3% | $89.3M | $43.1M | $0.90 | — |
| Q3 2024 | $478.7M | 15.4% | $28.4M | $16.1M | $0.33 | — |
| Q2 2024 | $486.3M | 13.6% | $30.1M | $19.2M | $0.40 | — |
| Q1 2024 | $404.4M | 17.0% | $30.1M | $14.8M | $0.31 | — |
| Q4 2023 | $353.0M | 11.0% | $-3.9M | $12.4M | $0.26 | — |
| FY 2023 | $1.39B | 15.5% | $84.6M | $60.7M | $1.29 | — |